Lamoste, Roscia .
HRN: 25-22-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/19/2024
09/20/2024
IV
500mg
Q8 X 4 Doses
Post OP Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes